Advertisement: TTP Killer 50

The Killer 50

  • Bragi harnesses Audio Analytic technology

    Cambridge-based Audio Analytic, a pioneer of sound recognition software, is incorporating its sound recognition capabilities into devices for German... Read More

  • 42 Technology steps on the gas for Linde

    Product design specialist 42 Technology is helping to develop a concept smart gas cylinder valve that will enable Linde Gases, a division of The... Read More

  • TTP Group celebrates 30th anniversary in style

    Cambridge-based technology hothouse TTP Group celebrated 30 years of innovation and product development with a party weekend for almost 700 staff and... Read More

  • Darktrace ramps capability of its AI cyber defence technology

    darktrace, Cambridge, cyber attacks

    Darktrace, the Cambridge-based world leader in AI technology for cyber defence, has launched a highly-specced third version of its Enterprise Immune... Read More

  • Abcam extends cell model contract with Horizon

    horizon discovery, gene-editing, cambridge

    Cambridge life science neighbours Abcam and Horizon Discovery are to continue working together on a crucial antibody research project. Abcam has... Read More

  • CMR Surgical

    Cambridge Medical Robotics

    Cambridge Medical Robotics is developing a next-gen universal robotic system for minimal access surgery. The company aims to make minimal access (... Read More

  • Checkit

    Checkit

    Checkit is an IoT-based digital solution that ensures compliance, delivers real-time control and saves staff time in food quality monitoring.... Read More

  • More ‘Killers’ on the loose in Cambridge Science and Tech cluster

    photorealism Robotae

    A new wave of AI and machine learning companies allied to a surging tide of activity in the hi-tech and Life Science sectors has brought fresh... Read More

  • PetaGene

    Vaughan Wittorff PetaGene

    Cambridge-based PetaGene software addresses challenges caused by growing volumes of genomics data.  Initially part of a project exploring new... Read More

  • Gearset

    The Redgate Software spin-out is bringing best practice to the Salesforce platform. Founded lin 2015, Gearset has rapidly established itself as... Read More

  • Evonetix

    Evonetix McCook

    Cambridge Consultants spin-out, Evonetix aims to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging... Read More

  • Focal Point Positioning

    Focal Point Positioning Ramsay

    Focal Point Positioning is a VC-backed start-up headquartered in Cambridge, UK. It was formed in 2015 by Dr Ramsey Faragher in order to solve a very... Read More

  • Glyconics

    Glyconics is at the forefront of diagnostic innovation, using infrared spectroscopy to analyse samples for proprietary markers of a broad range of... Read More

  • Nemesis Bioscience

    Nemesis is a new biopharma company developing Nemesis Symbiotics© – DNA therapeutics administered before antibiotics to inactivate resistance in... Read More

  • AudioTelligence

    AudioTelligence Robert Swann

    AudioTelligence is a spin-out company from CEDAR Audio Ltd (for nearly 30 years the world leader in audio restoration, dialogue noise suppression and... Read More

  • Global Inkjet Systems

    Global Inkjet Systems is a leading developer of industrial inkjet software, drive electronics, components and services. Its products drive thousands... Read More

  • BeanIoT

    BeanIoT Andrew Holland

    BeanIoT is a Cambridge-based startup providing a powerful ‘Out-of-the-Box’ Internet of Things (IoT) solution fit for use across a range of sectors... Read More

  • Cambridge Graphene Ltd

    Cambridge Graphene Ltd

    Cambridge Graphene is a spin-out from the University of Cambridge’s Graphene Centre. It supplies proprietary Graphene inks and undertakes development... Read More

  • Avacta

    Avacta laboratory

    Avacta has developed Affimer® technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly... Read More

  • ApcinteX

    Trevor Baglin Apcintex

    ApcinteX Ltd is seeking to disrupt the $10 billion haemophilia market by developing a drug that can be used in all patients, regardless of the type... Read More

Pages